CDC25A and hepatocellular carcinoma: Further explored in hepatocellular carcinoma where the overexpression was related to poor prognosis, CDC25A antisense oligo demonstrated the ability to decrease invasiveness but more importantly reduced cell proliferation and progression (Xu et al., 2008).